An investigation of the role of soluble CD14 in hospitalized, sick horses.

This research paper investigates the role of soluble CD14 (sCD14) in sick, hospitalized horses. The study found that the presence of sCD14 inhibits TNF-α production, and concentrations of sCD14 were found to be significantly higher in ill horses. However, the levels of sCD14 did not indicate the overall outcome for the horse.

Study Objectives

The study had two primary objectives:

• Firstly, it aimed to study the impact of soluble CD14 (sCD14) and monoclonal antibodies (mAb) to equine CD14 on TNF-α secretion from horse peripheral blood mononuclear cells (PBMC). TNF-α production is a key factor in the inflammatory response system of the horse’s body.
• Secondly, the researchers wanted to determine the sCD14 serum levels in a population of horses suffering from gastrointestinal diseases or other conditions likely to result in endotoxemia, which is the presence of endotoxins in the blood.

Methodology

The researchers managed to isolate PBMC from 10 healthy horses and incubated them with E. coli LPS along with CD14 mAb or sCD14, and then checked for TNF-α activity. LPS (lipopolysaccharides) are large molecules found in the outer membrane of certain bacteria, including E. coli and, when detected by the immune system, trigger strong immune responses. Additionally, they studied the blood samples from 55 sick horses and 23 healthy ones to determine the serum concentration of sCD14.

Findings

The findings of the study were as follows:

• A significant finding was that pre-incubation with CD14 mAb did not obstruct LPS-induced TNF-α production. However, the presence of sCD14 actually inhibited LPS-induced TNF-α production, with the level of inhibition being dependent on the concentration of sCD14 present.
• Another major finding was that concentrations of sCD14 in the blood were positively related to the respiratory rate, duration of clinical symptoms, and band neutrophil count, which are all indicators of illness in horses.
• The researchers found that serum sCD14 levels were significantly higher in the ill horses compared to the healthy horses, indicating that the production of sCD14 is increased in cases of illness.
• Despite the increased levels of sCD14 in sick horses, the study found no clear correlation between sCD14 levels and the outcome of the illness, suggesting that sCD14 levels may not be a clear indicator of the severity or prognosis of the disease.